舒泰神股价跌5.01%，广发基金旗下1只基金重仓，持有23.57万股浮亏损失41.95万元

Group 1 - The core point of the news is that Shuyou Shen's stock price dropped by 5.01% to 33.72 CNY per share, with a trading volume of 269 million CNY and a turnover rate of 1.73%, resulting in a total market capitalization of 16.11 billion CNY [1] - Shuyou Shen (Beijing) Biopharmaceutical Co., Ltd. was established on August 16, 2002, and went public on April 15, 2011. The company primarily engages in the research, production, and sales of biological products and some chemical drugs [1] - The main revenue composition of Shuyou Shen includes: 59.17% from injectable mouse nerve growth factor (Sutai), 33.19% from compound polyethylene glycol electrolyte powder, and 7.63% from other products [1] Group 2 - According to data from the top ten heavy stocks of funds, one fund under GF Fund holds Shuyou Shen as a significant investment. The GF Hong Kong-Shenzhen Medical Mixed A Fund (014114) held 235,700 shares in the second quarter, accounting for 2.86% of the fund's net value, ranking as the tenth largest heavy stock [2] - The GF Hong Kong-Shenzhen Medical Mixed A Fund (014114) was established on December 29, 2021, with a latest scale of 204 million CNY. The fund has achieved an 82% return this year, ranking 223 out of 8171 in its category, and a 95.07% return over the past year, ranking 681 out of 8004 [2] - The fund manager of GF Hong Kong-Shenzhen Medical Mixed A Fund is Wu Xingwu, who has a cumulative tenure of 10 years and 230 days. The total asset scale of the fund is 9.853 billion CNY, with the best fund return during his tenure being 112.46% and the worst being -32.66% [3]